-
-
Overview
-
Ertapenem Sodium is a broad-spectrum, β-lactam, a 1-beta-methyl carbapenem that interferes with peptidoglycan synthesis. Ertapenem has been commercially available since 2001 and is marked by Merck. Ertapenem binds to penicillin binding proteins located on the cell wall. It has a narrower spectrum of activity than imipenem. The compound is commonly used in antimicrobial susceptibility testing.
Ertapenem Sodium is freely soluble in water but practically insoluble in ethanol.Please contact us at for specific academic pricing.
Background
β-lactams interfere with PBP (penicillin binding protein) activity involved in the final phase of peptidoglycan synthesis. PBPs are enzymes which catalyze a pentaglycine crosslink between alanine and lysine residues, providing additional strength to the cell wall. Ertapanem binds to PBP 2 and PBP 3. Without a pentaglycine crosslink, the integrity of the cell wall is severely compromised and ultimately leads to cell lysis and death. Resistance to β-lactams is commonly due to cells containing plasmid-encoded β-lactamases. Erapenem is resistant to hydrolysis by a variety of β-lactamases, including penicillinases, cephalosporinases and extended-spectrum β-lactamases.
-
- Properties
- Applications
-
Overview